0.2707
-0.0021
(-0.77%)
As of 9:45:16 AM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-47,583.0010
-47,583.0010
-32,376.9740
-25,222.3010
-22,568.8380
Investing Cash Flow
-104.1950
-104.1950
-864.0380
-225.9710
-141.3610
Financing Cash Flow
61,410.8150
61,410.8150
22,939.6420
9,610.6550
1,248.7970
End Cash Position
23,288.6070
23,288.6070
9,564.9880
19,866.3580
35,703.9750
Capital Expenditure
-104.1950
-104.1950
-864.0380
-225.9710
-141.3610
Issuance of Capital Stock
--
--
22,150
9,610.6550
34.8730
Free Cash Flow
-47,687.1960
-47,687.1960
-33,241.0120
-25,448.2720
-22,710.1990
12/31/2021 - 11/10/2005
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ASMB Assembly Biosciences, Inc.
8.61
+1.77%
EPIX ESSA Pharma Inc.
1.5600
+2.67%
HLVX HilleVax, Inc.
1.5950
+2.90%
IPSC Century Therapeutics, Inc.
0.4188
+2.71%
SPRO Spero Therapeutics, Inc.
0.5850
+1.30%
GLTO Galecto, Inc.
2.1500
-3.14%
VTYX Ventyx Biosciences, Inc.
0.9301
+0.22%
NXTC NextCure, Inc.
0.2832
+4.89%
SEER Seer, Inc.
2.0050
-3.15%
ANTX AN2 Therapeutics, Inc.
1.2400
+2.48%